Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions.

Decraene C, Bortolini Silveira A, Michel M, Bidard FC, Pierga JY, Stern MH, Proudhon C.

J Vis Exp. 2018 Sep 25;(139). doi: 10.3791/58051.

PMID:
30320738
2.

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.

Decraene C, Silveira AB, Bidard FC, Vallée A, Michel M, Melaabi S, Vincent-Salomon A, Saliou A, Houy A, Milder M, Lantz O, Ychou M, Denis MG, Pierga JY, Stern MH, Proudhon C.

Clin Chem. 2018 Feb;64(2):317-328. doi: 10.1373/clinchem.2017.272518. Epub 2017 Nov 9.

PMID:
29122835
3.

Quantifying HER-2 expression on circulating tumor cells by ACCEPT.

Zeune L, van Dalum G, Decraene C, Proudhon C, Fehm T, Neubauer H, Rack B, Alunni-Fabbroni M, Terstappen LWMM, van Gils SA, Brune C.

PLoS One. 2017 Oct 30;12(10):e0186562. doi: 10.1371/journal.pone.0186562. eCollection 2017.

4.

Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.

Ignatiadis M, Rack B, Rothé F, Riethdorf S, Decraene C, Bonnefoi H, Dittrich C, Messina C, Beauvois M, Trapp E, Goulioti T, Tryfonidis K, Pantel K, Repollet M, Janni W, Piccart M, Sotiriou C, Litiere S, Pierga JY.

Eur J Cancer. 2016 Aug;63:97-104. doi: 10.1016/j.ejca.2016.04.024. Epub 2016 Jun 10. Review.

PMID:
27289552
5.

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.

Lebofsky R, Decraene C, Bernard V, Kamal M, Blin A, Leroy Q, Rio Frio T, Pierron G, Callens C, Bieche I, Saliou A, Madic J, Rouleau E, Bidard FC, Lantz O, Stern MH, Le Tourneau C, Pierga JY.

Mol Oncol. 2015 Apr;9(4):783-90. doi: 10.1016/j.molonc.2014.12.003. Epub 2014 Dec 26.

6.

H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC.

Carotenuto M, De Antonellis P, Liguori L, Benvenuto G, Magliulo D, Alonzi A, Turino C, Attanasio C, Damiani V, Bello AM, Vitiello F, Pasquinelli R, Terracciano L, Federico A, Fusco A, Freeman J, Dale TC, Decraene C, Chiappetta G, Piantedosi F, Calabrese C, Zollo M.

Oncotarget. 2014 Jul 30;5(14):5736-49.

7.

Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.

Moumen M, Chiche A, Decraene C, Petit V, Gandarillas A, Deugnier MA, Glukhova MA, Faraldo MM.

Mol Cancer. 2013 Oct 30;12(1):132. doi: 10.1186/1476-4598-12-132.

8.

Cancer stemness in Wnt-driven mammary tumorigenesis.

Monteiro J, Gaspar C, Richer W, Franken PF, Sacchetti A, Joosten R, Idali A, Brandao J, Decraene C, Fodde R.

Carcinogenesis. 2014 Jan;35(1):2-13. doi: 10.1093/carcin/bgt279. Epub 2013 Aug 16.

PMID:
23955540
9.

Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation.

Atlasi Y, Noori R, Gaspar C, Franken P, Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ, Fodde R.

PLoS Genet. 2013 May;9(5):e1003424. doi: 10.1371/journal.pgen.1003424. Epub 2013 May 2.

10.

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.

Ligthart ST, Bidard FC, Decraene C, Bachelot T, Delaloge S, Brain E, Campone M, Viens P, Pierga JY, Terstappen LW.

Ann Oncol. 2013 May;24(5):1231-8. doi: 10.1093/annonc/mds625. Epub 2012 Dec 27.

PMID:
23275633
11.

Gene expression profiling to dissect the complexity of cancer biology: pitfalls and promise.

Raspe E, Decraene C, Berx G.

Semin Cancer Biol. 2012 Jun;22(3):250-60. doi: 10.1016/j.semcancer.2012.02.011. Epub 2012 Mar 7. Review.

PMID:
22459768
12.

Concepts of metastasis in flux: the stromal progression model.

Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, Decraene C, Rüegg C.

Semin Cancer Biol. 2012 Jun;22(3):174-86. doi: 10.1016/j.semcancer.2012.02.007. Epub 2012 Feb 21. Review.

13.

Molecular profiling of patient-derived breast cancer xenografts.

Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E.

Breast Cancer Res. 2012 Jan 16;14(1):R11.

14.

Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells.

Mordant P, Loriot Y, Lahon B, Castier Y, Lesèche G, Soria JC, Vozenin MC, Decraene C, Deutsch E.

PLoS One. 2011;6(10):e26073. doi: 10.1371/journal.pone.0026073. Epub 2011 Oct 11.

15.

Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients.

Reyal F, Valet F, de Cremoux P, Mathiot C, Decraene C, Asselain B, Brain E, Delaloge S, Giacchetti S, Marty M, Pierga JY, Bidard FC.

Ann Oncol. 2011 Jun;22(6):1458-9. doi: 10.1093/annonc/mdr144. Epub 2011 Apr 27. No abstract available.

PMID:
21525400
16.

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.

Meyniel JP, Cottu PH, Decraene C, Stern MH, Couturier J, Lebigot I, Nicolas A, Weber N, Fourchotte V, Alran S, Rapinat A, Gentien D, Roman-Roman S, Mignot L, Sastre-Garau X.

BMC Cancer. 2010 May 21;10:222. doi: 10.1186/1471-2407-10-222.

17.

New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling.

Schibler L, Gibbs L, Benoist-Lasselin C, Decraene C, Martinovic J, Loget P, Delezoide AL, Gonzales M, Munnich A, Jais JP, Legeai-Mallet L.

PLoS One. 2009 Oct 29;4(10):e7633. doi: 10.1371/journal.pone.0007633.

18.

Evaluation of methods for amplification of picogram amounts of total RNA for whole genome expression profiling.

Clément-Ziza M, Gentien D, Lyonnet S, Thiery JP, Besmond C, Decraene C.

BMC Genomics. 2009 May 26;10:246. doi: 10.1186/1471-2164-10-246.

19.

Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.

Trolet J, Hupé P, Huon I, Lebigot I, Decraene C, Delattre O, Sastre-Garau X, Saule S, Thiéry JP, Plancher C, Asselain B, Desjardins L, Mariani P, Piperno-Neumann S, Barillot E, Couturier J.

Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2572-80. doi: 10.1167/iovs.08-2296. Epub 2009 Jan 17.

PMID:
19151381
20.

ITALICS: an algorithm for normalization and DNA copy number calling for Affymetrix SNP arrays.

Rigaill G, Hupé P, Almeida A, La Rosa P, Meyniel JP, Decraene C, Barillot E.

Bioinformatics. 2008 Mar 15;24(6):768-74. doi: 10.1093/bioinformatics/btn048. Epub 2008 Feb 5.

PMID:
18252739
21.

High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.

Bollet MA, Servant N, Neuvial P, Decraene C, Lebigot I, Meyniel JP, De Rycke Y, Savignoni A, Rigaill G, Hupé P, Fourquet A, Sigal-Zafrani B, Barillot E, Thiery JP.

J Natl Cancer Inst. 2008 Jan 2;100(1):48-58. Epub 2007 Dec 25.

PMID:
18159071
22.

Challenges in the stratification of breast tumors for tailored therapies.

Thiery JP, Sastre-Garau X, Vincent-Salomon B, Sigal-Zafrani X, Pierga JY, Decraene C, Meyniel JP, Gravier E, Asselain B, De Rycke Y, Hupe P, Barillot E, Ajaz S, Faraldo M, Deugnier MA, Glukhova M, Medina D; Breast Cancer Group.

Bull Cancer. 2006 Aug;93(8):E81-9. Review.

23.

Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.

Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G.

Eur Cytokine Netw. 2005 Dec;16(4):289-92.

24.

Global transcriptional characterization of SP and MP cells from the myogenic C2C12 cell line: effect of FGF6.

Decraene C, Benchaouir R, Dillies MA, Israeli D, Bortoli S, Rochon C, Rameau P, Pitaval A, Tronik-Le Roux D, Danos O, Gidrol X, Garcia L, Piétu G.

Physiol Genomics. 2005 Oct 17;23(2):132-49. Epub 2005 Jul 20.

PMID:
16033864
25.

Zyxin is up-regulated during megakaryocytic differentiation of human UT-7/c-mpl cells.

Decraene C, Garçon L, Lacout C, Sabri S, Auffray C, Vainchenker W, Duménil D, Piétu G, Svinartchuk F.

Biochem Biophys Res Commun. 2004 May 28;318(2):439-43.

PMID:
15120620
26.

Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology.

Benchaouir R, Rameau P, Decraene C, Dreyfus P, Israeli D, Piétu G, Danos O, Garcia L.

Exp Cell Res. 2004 Mar 10;294(1):254-68.

PMID:
14980519
27.

Complementary DNA arrays identify CD63 tetraspanin and alpha3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells.

Sordat I, Decraene C, Silvestre T, Petermann O, Auffray C, Piétu G, Sordat B.

Lab Invest. 2002 Dec;82(12):1715-24.

PMID:
12480921
28.

Identification of genes involved in ceramide-dependent neuronal apoptosis using cDNA arrays.

Decraene C, Brugg B, Ruberg M, Eveno E, Matingou C, Tahi F, Mariani J, Auffray C, Pietu G.

Genome Biol. 2002 Jul 31;3(8):RESEARCH0042. Epub 2002 Jul 31.

29.

Automatic quantitation of hybridization signals on cDNA arrays.

Tahi F, Achddou B, Decraene C, Alibert O, Guiot H, Auffray C, Piétu G.

Biotechniques. 2002 Jun;32(6):1386-8, 1390, 1392, 1394, 1396-7.

30.

Expression profiling using quantitative hybridization on macroarrays.

Piétu G, Decraene C.

Methods Mol Biol. 2002;185:425-32. Review. No abstract available.

PMID:
11769006
31.
32.

The Genexpress IMAGE knowledge base of the human brain transcriptome: a prototype integrated resource for functional and computational genomics.

Piétu G, Mariage-Samson R, Fayein NA, Matingou C, Eveno E, Houlgatte R, Decraene C, Vandenbrouck Y, Tahi F, Devignes MD, Wirkner U, Ansorge W, Cox D, Nagase T, Nomura N, Auffray C.

Genome Res. 1999 Feb;9(2):195-209.

Supplemental Content

Loading ...
Support Center